The Oncology Institute, Inc. TOI Convertible Preferred Stock Converted to Other Securities
Convertible Preferred Stock Converted to Other Securities at other companies
Other financials
Where this comes from
Reported directly by The Oncology Institute, Inc. in its filing.
Tagged under the XBRL concept us-gaap:ConvertiblePreferredStockConvertedToOtherSecurities.
The official record: The Oncology Institute, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about The Oncology Institute, Inc.'s convertible preferred stock converted to other securities.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is The Oncology Institute, Inc.'s convertible preferred stock converted to other securities?
- The Oncology Institute, Inc. (TOI) reported convertible preferred stock converted to other securities of $0 in Q1 2026.
- How has The Oncology Institute, Inc.'s convertible preferred stock converted to other securities changed year-over-year?
- The Oncology Institute, Inc.'s convertible preferred stock converted to other securities decreased by 100.0% year-over-year, from $4.11M to $0.
- What does convertible preferred stock converted to other securities mean?
- Tracks the non-cash transaction volume where preferred equity is exchanged for common stock or other financial instruments. This metric is critical for understanding changes in the capital structure and potential dilution for existing common shareholders.